But one of the most mind-bending is the low probability prediction that one of the five companies expected to launch a drug next year will actually manage to deliver good stock performance.

FORBES: Biotech, Where Winners Lose

Barring a ferocious bear stockmarket, on past performance WorldCom's stock will be a good deal more valuable at the end of such a wait than it is today.

ECONOMIST: The bids for MCI

It has a lot to do with the recent performance of the stock market, a pretty good measure of sentiment as well as one of the better leading indicators of real economic activity.

FORBES: The Economy Glass Getting Half Full

My charts on the coefficient of performance among stock sectors show lessened correlation, a good sign.

FORBES: Magazine Article

The weak relative performance over the past year was a good reason not to buy this stock as it has made lower highs, line c.

FORBES: Can Earnings Revive a Weakening Market?

Maybe not quite as good as last year, but executive compensation is likely to rise significantly given the positive performance of the stock market so far and the continued improvement of corporate earnings.

FORBES: Executive Compensation's New Normal: A Missed Opportunity